Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Eitemau Tebyg

• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  gan: Kobayashi, Susumu, et al.
  Cyhoeddwyd: (2013)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  gan: Costa, Daniel B, et al.
  Cyhoeddwyd: (2007)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  gan: Daniel B. Costa, et al.
  Cyhoeddwyd: (2007)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  gan: Norihiro Yamaguchi, et al.
  Cyhoeddwyd: (2013)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  gan: Yamaguchi, Norihiro, et al.
  Cyhoeddwyd: (2013)